MRUS Stock Analysis: Buy, Sell, or Hold?
MRUS - Merus N.V. Common Shares
$90.00
-6.92 (-7.14%)
▼
5d:
-7.17%
30d:
-6.34%
90d:
-3.92%
HOLD
MODERATE Confidence
Analysis Updated: Dec 29, 2025 12:00 AM ET
Earnings: May 13, 2026
0d
Get Alerted When MRUS Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
1 traders called MRUS this week
100% bullish • 0 bearish
100% bullish • 0 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: MRUS shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: MRUS shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: MRUS is currently trading at $90.00, which is considered fair based on recent price action.
Technical Outlook: Technically, MRUS is in a strong uptrend. Immediate support is located at $87.14, while resistance sits at $97.14. Short-term momentum is weak, with the stock down 7.1% recently.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, MRUS is in a strong uptrend. Immediate support is located at $87.14, while resistance sits at $97.14. Short-term momentum is weak, with the stock down 7.1% recently.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
FAIR
Company Quality Score
55/100
(HOLD)
Volume Confirmation
UNKNOWN
Confidence Score
58.9%
All Signals
- NEUTRAL: Price in fair range
- NEUTRAL: Mixed technical signals (55/100)
- BEARISH: Downward momentum (-7.1%)
- NEUTRAL: Near Wall St target ($97.00)
- CAUTION: 5-day price weakness (-7.2%) - monitor closely
Support & Resistance Levels
Support Level
$87.14
Resistance Level
$97.14
Current Trend
Strong Uptrend
Technical data as of
Dec 29, 2025
Fundamental Context
Forward P/E (Next Year Est.)
-19.45
Wall Street Target
$97.00
(+7.8%)
Revenue Growth (YoY)
3.2%
Share & Embed Analysis
Last updated: May 14, 2026 10:42 AM ET
Data refreshes hourly during market hours. Next update: 11:42 AM
Data refreshes hourly during market hours. Next update: 11:42 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is MRUS showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NTLA
Intellia Therapeutics Inc |
STRONG BUY
29 analysts |
$27 | 57 HOLD |
|
ONC
BeiGene, Ltd. |
STRONG BUY
24 analysts |
$411 | 59 HOLD |
|
AXSM
Axsome Therapeutics Inc |
STRONG BUY
19 analysts |
$270 | 55 HOLD |
|
INCY
Incyte Corporation |
HOLD
27 analysts |
$109 | 64 BUY |
|
CRNX
Crinetics Pharmaceutical… |
STRONG BUY
17 analysts |
$84 | 55 HOLD |